Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDFT1 | P37268 | 7/20 | 0.56 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.41 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9661622 | 0.87 | FDFT1 (0.53) | FDFT1FDPSENPP2S1PR2S1PR1 | |
| SCHEMBL9544118 | 0.85 | FDFT1 (0.71) | FDFT1 | |
| SCHEMBL9663262 | 0.84 | FDFT1 (0.53) | FDFT1 | |
| SCHEMBL3885276 | 0.83 | FDFT1 (0.51) | FDFT1ENPP2S1PR2S1PR1S1PR3 | |
| SCHEMBL1237801 | 0.82 | FDFT1 (0.61) | FDFT1 | |
| SCHEMBL9662849 | 0.81 | FDPS (0.62) | FDFT1FDPSENPP2S1PR2S1PR1 | |
| SCHEMBL9632927 | 0.81 | FDPS (0.57) | FDFT1FDPSENPP2S1PR2S1PR1 | |
| SCHEMBL9663350 | 0.81 | FDFT1 (0.50) | FDFT1S1PR2S1PR1S1PR3 | |
| SCHEMBL9663772 | 0.81 | FDFT1 (0.47) | FDFT1FDPSS1PR2S1PR1S1PR3 | |
| SCHEMBL413324 | 0.81 | FDFT1 (0.60) | FDFT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120022024-A1 | ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120022024-A1 | ANTI-BACTERIAL COMPOSITIONS AND METHODS INCLUDING TARGETING VIRULENCE FACTORS OF STAPHYLOCOCCUS AUREUS | CUTA, MMP8, CLPP | FDFT1 1987/4885FDPS 2463/4885ENPP2 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.